Finding equipoise: CEPI revises its equitable access policy.

Finding equipoise: CEPI revises its equitable access policy. Vaccine. 2020 Jan 28;: Authors: Huneycutt B, Lurie N, Rotenberg S, Wilder R, Hatchett R Abstract Launched at Davos in January 2017 with funding from sovereign investors and philanthropic institutions, the Coalition for Epidemic Preparedness Innovations (CEPI) is an innovative partnership between public, private, philanthropic, and civil organisations whose mission is to stimulate, finance and co-ordinate vaccine development against diseases with epidemic potential in cases where market incentives fail. As of December 2019, CEPI has committed to investing up to $706 million in vaccine development. This includes 19 vaccine candidates against its priority pathogens (Lassa fever virus, Middle East respiratory syndrome coronavirus, Nipah virus, Chikungunya, Rift Valley fever) and three vaccine platforms to develop vaccines against Disease X, a novel or unanticipated pathogen. As an entity largely supported by public funds, ensuring equitable access to vaccines whose development it supports in low- and middle-income countries is CEPI's primary focus. CEPI developed an initial equitable access policy shortly after its formation, with key stakeholders expressing strong views about its content and prescriptive nature. The CEPI board instructed that it be revisited after a year. This paper describes the process of revising the policy, and how key issues were resolved. CEPI will continue to take an iterat...
Source: Vaccine - Category: Allergy & Immunology Authors: Tags: Vaccine Source Type: research

Related Links:

The number of disorders associated with congenital or acquired asplenia and functional hyposplenism has increased substantially over the past couple decades. Previously, screening for asplenia and hyposplenism was a barrier to identifying patients at risk. Recent methods for measuring splenic function have emerged as accurate and reliable. Identifying patients prevents overwhelming postsplenectomy infection or invasive pneumococcal disease. Approaches to protect patients with asplenia or hyposplenism include patient education of risks and signs/symptoms of infection, vaccination, and antibiotic prophylaxis. Physicians have...
Source: Immunology and Allergy Clinics of North America - Category: Allergy & Immunology Authors: Source Type: research
Evaluation of antibodies produced after immunization is central to immune deficiency diagnosis. This includes assessment of responses to routine immunizations as well as to vaccines administered specifically for diagnosis. Here, we present the basic concepts of the humoral immune response and their relevance for vaccine composition and diagnosis of immune deficiency. Current vaccines are discussed, including nonviable protein and glycoprotein vaccines, pure polysaccharide vaccines, polysaccharide –protein conjugate vaccines, and live agent vaccines. Diagnostic and therapeutic applications of vaccine antibody measurem...
Source: Immunology and Allergy Clinics of North America - Category: Allergy & Immunology Authors: Source Type: research
We report this consensus to support allergists and clinical immunologists to make optimal decisions under the urgent situation in Asia. PMID: 32638559 [PubMed]
Source: Allergy, Asthma and Immunology Research - Category: Allergy & Immunology Tags: Allergy Asthma Immunol Res Source Type: research
Authors: Naik R, Peden K Abstract Developing traditional viral vaccines for infectious diseases usually takes years, as these are usually produced either by chemical inactivation of the virus or attenuation of the pathogen, processes that can take considerable time to validate and also require the live pathogen. With the advent of nucleic-acid vaccines (DNA and mRNA), the time to vaccine design and production is considerably shortened, since once the platform has been established, all that is required is the sequence of the antigen gene, its synthesis and insertion into an appropriate expression vector; importantly...
Source: Current Topics in Microbiology and Immunology - Category: Microbiology Tags: Curr Top Microbiol Immunol Source Type: research
Publication date: Available online 9 July 2020Source: Journal of Microbiology, Immunology and InfectionAuthor(s): Pei-Hsuan Tsai, Mao-Song Tsai, Yin-Hsuan Chiang, Chung-Yu Shih, Chia-Ying Liu, Yu-Chung Chuang, Chia-Jui Yang
Source: Journal of Microbiology, Immunology and Infection - Category: Microbiology Source Type: research
Covid-19 outbreak accelerates across Africa; Venezuelan Socialist Party boss also tests positive; Brazilian President Jair Bolsonaro ‘in good health’. Follow the latest updates:South Africa warns of coronavirus ‘storm’ as outbreak accelerates across continentBolivia ’s president and Venezuela’s Socialist party leader test positive for Covid-19WHO says coronavirus pandemic still acceleratingTrudeau and Trump ’s responses see wildly different results1.54amBSTPlans for the fall semester at the University ofCalifornia, Berkeley, are in question after 47 new Covid-19 cases tied to frate...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Coronavirus outbreak World news UK news US news Australia news Science Infectious diseases Africa Microbiology Medical research Source Type: news
Publication date: Available online 8 July 2020Source: Medicina Intensiva (English Edition)Author(s): A. González-Castro, P. Escudero-Acha, Y. Peñasco, O. Leizaola, V. Martínez de Pinillos Sánchez, A. García de Lorenzo
Source: Medicina Intensiva - Category: Intensive Care Source Type: research
WHO says pandemic is still accelerating; Hundreds of Romanians check themselves out of hospital; Serbia considers new lockdown. This blog is now closedFollow the latest global coronavirus live blog hereWHO says coronavirus pandemic still acceleratingWarning of Covid-19 ‘storm’ as pandemic accelerates across AfricaTrudeau and Trump ’s responses see wildly different results12.39amBSTWe ’ve launched a new blog at the link below – head there for the latest:Related:Coronavirus live news: Bolivia president tests positive amid record rise in South Africa cases12.05amBSTSouth Africa announced Thursday...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Coronavirus outbreak World news US news Australia news UK news Science Infectious diseases Source Type: news
Novavax will earn $1.6 billion for its vaccine and Regeneron $450 million for its antibodies
Source: Chemical and Engineering News - Category: Chemistry Authors: Source Type: research
These are the coronavirus stories you need to know about today.Medscape Medical News
Source: Medscape Internal Medicine Headlines - Category: Internal Medicine Tags: Infectious Diseases News Source Type: news
More News: Allergy & Immunology | Chikungunya | Coccidioidomycosis (Valley Fever) | Coronavirus | Epidemics | Epidemiology | Funding | Lassa Fever | MERS | Middle East Health | Nipah Virus | Partnerships | Respiratory Medicine | Science | Vaccines